Lung cancer remains the leading cause of cancer-related death in Canada, claiming nearly 21,000 lives in 2024. In response, the Canadian Cancer Society (CCS), has launched 2026–2035 Pan-Canadian Lung ...
October 2025 proved to be a significant month for the oncology landscape, marked by a wave of key regulatory decisions from the US FDA. This period saw important full and accelerated drug approvals ...
A Royal Stoke patient has become the first in the UK to be recruited onto a major new international small-cell lung cancer ...
The Syracuse Crunch partnered with the Upstate Cancer Center for "Shine a Light on Lung Cancer Night" at the Upstate Medical ...
Leslie Stoll was an active athlete who had never smoked. She was shocked when a chance scan spotted something unusual.
Most New York City Marathon runners simply aim to cross the finish line, but Terence Hartnett wants to set a new world record ...
The study will test the antibody-drug conjugate in combination with Keytruda in patients with HER2-overexpressing metastatic non-small cell lung cancer.
Obesity is a modifiable risk factor for a number of conditions, including inflammatory and malignant lung disease, and is now ...
People living with HIV who smoke are currently more likely to die from lung cancer than from HIV-related causes. Two cancer ...
Cancer patients who got an mRNA COVID vaccine within a few months of their immunotherapy lived longer than those who did not, health records show.
The observation that mRNA vaccines can sensitize tumors to immunotherapy has researchers eager to test how mRNA’s ability to activate the immune system could be harnessed in oncology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback